Tony-Whetton-photo

Professor Anthony Whetton

In Speakers London 2016 by PMF Conferences

Biography

Professor Tony Whetton is Director of the Stoller Centre for Biomarker Discovery and also the Manchester Precision Medicine Institute. He is also principal investigator of the Bloodwise Mass Spectrometry programme based at the Wolfson Molecular Imaging Centre, Christie Hospital.

Tony was appointed Professor of Cell Biology in 1995 and Head of Department of Biomolecular Sciences at University of Manchester Institute of Science and Technology. He then joined the School of Medicine at Manchester University in 2003 as Professor of Cancer Cell Biology, based at the Christie Hospital. Here he established a state of the art biological mass spectrometry facility for stem cell and cancer research. This platform has been extended into biomarker research for precision medicine in recent years.

In his leukaemia research Tony is currently systematically defining the downstream proteomic and phosphoproteomic effects of the protein tyrosine kinases associated with myeloproliferative disorders and myeloid leukaemias to discover common mechanisms for leukaemic transformation and thus new drug targets. This has lead to a new approach to extinguish chronic myeloid leukaemia stem cells. He is in the process of building a new £3 million laboratory to house the Stoller Biomarker Discovery Centre which has £25 million of funding to date and opened in June 2016. As Director of the Manchester Precision Medicine Institute Tony Whetton leads on enabling researchers, clinicians and industry to work together for improving clinical outcomes.